Why Are Stryker Rejuvenate and ABG II Hip Implants Being Recalled?

In June of 2012, Stryker voluntarily recalled the Rejuvenate and ABG II modular-neck stem hip replacement systems due to increased reports of fretting and corrosion at the modular-neck junction.

Approved by the U.S. Food and Drug Administration (FDA) in June 2008 and November 2009, the Rejuvenate and ABG II systems were marketed to younger and more active patients. The devices were touted as providing enhanced stability and flexibility by allowing surgeons to closely match the biomechanics of each patient and by reducing the risk of dislocations and costly revision surgeries. According to Stryker, approximately 30,000 Rejuvenate and ABG II systems have implanted in patients since 2007.

The trial lawyers at Bottar Leone, PLLC, have decades of experience investigating, prosecuting and trying to verdict product liability cases stemming from injuries caused by products that have been recalled because they are defective.  If you or a loved one have a Stryker hip, you and your family may be entitled to compensation for lifelong health care, medical expenses, medical bills, loss of income, and pain and suffering. 

To discuss your case or concerns with an experienced Syracuse New York Stryker hip recall attorney, contact us now at (315) 422-3466, (800) 336-LAWS, or by e-mail at info@bottarleone.com.